The Irish Times interviewed Prof Luke O'Neill about his research in using small molecules to block inflammation. Early mice studies show exceptional promise in blocking multiple sclerosis, and additional tests reveal the molecules could also halt diseases such as rheumatoid arthritis and alzheimer’s. Read the full article here.